Sara Bravaccini

3.0k total citations
125 papers, 2.1k citations indexed

About

Sara Bravaccini is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sara Bravaccini has authored 125 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Oncology, 42 papers in Cancer Research and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sara Bravaccini's work include HER2/EGFR in Cancer Research (24 papers), Breast Cancer Treatment Studies (21 papers) and Advanced Breast Cancer Therapies (18 papers). Sara Bravaccini is often cited by papers focused on HER2/EGFR in Cancer Research (24 papers), Breast Cancer Treatment Studies (21 papers) and Advanced Breast Cancer Therapies (18 papers). Sara Bravaccini collaborates with scholars based in Italy, Spain and Tanzania. Sara Bravaccini's co-authors include Dino Amadori, Andrea Rocca, Sara Ravaioli, Roberta Maltoni, Maria Maddalena Tumedei, Maurizio Puccetti, Francesca Pirini, Daniele Calistri, Giuseppe Bronte and Paola Ulivi and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sara Bravaccini

115 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Bravaccini Italy 27 922 806 700 659 215 125 2.1k
Ricardo Costa United States 22 1.1k 1.2× 848 1.1× 601 0.9× 540 0.8× 204 0.9× 82 2.2k
Jianjun He China 27 837 0.9× 940 1.2× 433 0.6× 846 1.3× 286 1.3× 86 2.2k
Yohei Masugi Japan 31 1.1k 1.2× 857 1.1× 677 1.0× 617 0.9× 554 2.6× 127 2.9k
Murry W. Wynes United States 28 879 1.0× 888 1.1× 1.2k 1.7× 553 0.8× 189 0.9× 56 2.4k
Pierre Saintigny France 28 996 1.1× 1.2k 1.5× 521 0.7× 704 1.1× 236 1.1× 131 2.5k
Nils Brünner Denmark 29 1.0k 1.1× 1.2k 1.5× 322 0.5× 972 1.5× 165 0.8× 96 2.4k
Toru Kumagai Japan 32 1.4k 1.5× 1.1k 1.3× 1.4k 2.0× 741 1.1× 179 0.8× 156 3.1k
Guido Bellezza Italy 28 1.0k 1.1× 830 1.0× 942 1.3× 581 0.9× 247 1.1× 124 2.4k
Junichi Inokuchi Japan 28 478 0.5× 1.1k 1.4× 1.0k 1.5× 533 0.8× 401 1.9× 161 2.4k
Michael Fraser Canada 24 562 0.6× 1.4k 1.7× 561 0.8× 479 0.7× 192 0.9× 47 2.3k

Countries citing papers authored by Sara Bravaccini

Since Specialization
Citations

This map shows the geographic impact of Sara Bravaccini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Bravaccini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Bravaccini more than expected).

Fields of papers citing papers by Sara Bravaccini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Bravaccini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Bravaccini. The network helps show where Sara Bravaccini may publish in the future.

Co-authorship network of co-authors of Sara Bravaccini

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Bravaccini. A scholar is included among the top collaborators of Sara Bravaccini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Bravaccini. Sara Bravaccini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leo, Michael C., et al.. (2026). Reframing Obesity in Knee Osteoarthritis: A Call for a Transdisciplinary Approach Beyond Biomechanics. Arthroscopy The Journal of Arthroscopic and Related Surgery. 42(1). 14–15.
2.
3.
Nehme, Jamil, Sara Bravaccini, Michele Zanoni, et al.. (2025). Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer. The EMBO Journal. 44(7). 1921–1942. 2 indexed citations
4.
Nicolini, Fabio, Roberta Maltoni, Matteo Marchesini, et al.. (2024). Significant Advancements and Evolutions in Chimeric Antigen Receptor Design. International Journal of Molecular Sciences. 25(22). 12201–12201. 4 indexed citations
5.
Cortesi, Michela, Sara Bravaccini, Sara Ravaioli, et al.. (2024). HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer. Cancers. 16(22). 3752–3752.
6.
7.
Barozzi, Iros, Neil Slaven, Rui Lopes, et al.. (2024). A Functional Survey of the Regulatory Landscape of Estrogen Receptor–Positive Breast Cancer Evolution. Cancer Discovery. 14(9). 1612–1630. 5 indexed citations
8.
Gianni, Caterina, Michela Palleschi, Filippo Merloni, et al.. (2024). A Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors. Biomedicines. 12(10). 2183–2183. 6 indexed citations
9.
Miserocchi, Giacomo, Martine Bocchini, Michela Cortesi, et al.. (2023). Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension. Frontiers in Immunology. 14. 1171141–1171141. 25 indexed citations
10.
Bravaccini, Sara, Roberta Maltoni, Claudio Cerchione, et al.. (2022). T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer. International Journal of Molecular Sciences. 23(15). 8590–8590. 22 indexed citations
11.
Cortesi, Michela, Michele Zanoni, Roberta Maltoni, et al.. (2022). TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancer. Expert Opinion on Therapeutic Targets. 26(7). 593–602. 14 indexed citations
12.
Maltoni, Roberta, Tania Rossi, Francesco� Fabbri, et al.. (2022). Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study. Current Oncology. 29(2). 433–438. 1 indexed citations
13.
Bravaccini, Sara & Roberta Maltoni. (2021). Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls. Journal of Personalized Medicine. 11(11). 1211–1211. 11 indexed citations
14.
Cortesi, Michela, Michele Zanoni, Francesca Pirini, et al.. (2021). Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight. International Journal of Molecular Sciences. 23(1). 254–254. 45 indexed citations
15.
Simeone, Pasquale, Stefano Tacconi, Serena Longo, et al.. (2021). Expanding Roles of De Novo Lipogenesis in Breast Cancer. International Journal of Environmental Research and Public Health. 18(7). 3575–3575. 36 indexed citations
16.
Cerchione, Claudio, Giovanni Martinelli, Marco Picardi, et al.. (2020). Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial. Journal of Clinical Medicine. 9(2). 395–395. 6 indexed citations
17.
Coco, Laura Del, Daniele Vergara, Serena De Matteis, et al.. (2019). NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus. Journal of Clinical Medicine. 8(5). 720–720. 52 indexed citations
18.
Masalu, Nestory, Patrizia Serra, Dino Amadori, et al.. (2017). Setting up a community-based cervical screening service in a low-income country: a pilot study from north-western Tanzania. International Journal of Public Health. 62(7). 755–762. 7 indexed citations
19.
Tumedei, Maria Maddalena, Rosella Silvestrini, Sara Ravaioli, et al.. (2015). Role of Androgen and Estrogen Receptors as Prognostic and Potential Predictive Markers of Ductal Carcinoma in Situ of the Breast. The International Journal of Biological Markers. 30(4). 425–428. 14 indexed citations
20.
Bravaccini, Sara, Laura Medri, Roberta Gunelli, et al.. (2004). Urine Telomerase: An Important Marker in the Diagnosis of Bladder Cancer. Neoplasia. 6(3). 234–239. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ricardo Costa Breakdown of academic impact, for papers by Jianjun He Breakdown of academic impact, for papers by Yohei Masugi Breakdown of academic impact, for papers by Murry W. Wynes Breakdown of academic impact, for papers by Pierre Saintigny Breakdown of academic impact, for papers by Nils Brünner Breakdown of academic impact, for papers by Toru Kumagai Breakdown of academic impact, for papers by Guido Bellezza Breakdown of academic impact, for papers by Junichi Inokuchi Breakdown of academic impact, for papers by Michael Fraser
Rankless by CCL
2026